<rss version="2.0" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:trackback="http://madskills.com/public/xml/rss/module/trackback/"><channel><title>Agency for Science Technology and Research (A*STAR)</title><link>http://www.a-star.edu.sg</link><description>RSS feeds for Agency for Science Technology and Research (A*STAR)</description><ttl>60</ttl><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1826/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1826</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1826&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Agilent Technologies, University of Rouen and A*STAR’S Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1826/Default.aspx</link><description>
 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
  
  
   
   
   
   
   
   
   
   
   
   
   
  


 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-style-parent:"";
	font-size:11.0pt;"Calibri","sans-serif";
	mso-fareast-"Times New Roman";
	mso-bidi-"Times New Roman";}


Agilent Technologies Inc. (NYSE: A), the Glyco-MEV laboratory at the University of Rouen, in France,&amp;#160;and the Bioprocessing Technology Institute at the Agency for Science, Technology and Research (A*STAR) in Singapore, have signed a memorandum of understanding to work together to develop tools to effectively analyze biologics and vaccines.</description><dc:creator>Alfi</dc:creator><pubDate>Thu, 23 May 2013 01:14:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1826</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1825/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1825</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1825&amp;PortalID=0&amp;TabID=828</trackback:ping><title>First ARKRAY overseas R&amp;D center to be incubated in Singapore’s Institute of Bioengineering and Nanotechnology</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1825/Default.aspx</link><description>Singapore, May 22, 2013 – ARKRAY, Inc. has set up its first Asian research center outside Japan in Singapore’s Institute of Bioengineering and Nanotechnology (IBN). The company will invest $9.1 million over a 5-year period in this research venture and collaboration.</description><dc:creator>Alfi</dc:creator><pubDate>Wed, 22 May 2013 02:25:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1825</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1824/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1824</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1824&amp;PortalID=0&amp;TabID=828</trackback:ping><title>QuantuMDx and Genome Institute of Singapore announce collaboration to develop Asia-specific assays on QuantuMDx’s Q-POC™</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1824/Default.aspx</link><description>A*STAR’s Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devices. Under this collaboration, QMDx’s wholly owned Singapore-based subsidiary QMDx Asia and GIS will develop Asia-specific point-of-care genetic tests for use with Q-POC™, QMDx’s handheld point-of-care device.&amp;#160; QMDx will commercialize the tests. The first assay from the development pipeline will direct treatment of East Asian patients with kinase-driven cancers, such as chronic myeloid leukemia (CML) and epidermal growth factor receptor-mutated non-small lung cancer (EGFR NSCLC).</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Tue, 21 May 2013 02:06:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1824</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1823/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1823</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1823&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A better quality of life, thanks to the science of measurement</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1823/Default.aspx</link><description>Whether you’re comparing the weight of the bak kwa you buy every Chinese New Year, following the doctor’s prescribed dose of medicine, or determining which light bulb conserves energy for your home, all these units of measurement you use regularly are results of metrology, the science of measurement. This year’s World Metrology Day, “Measurements in Daily Life”, celebrates metrology’s contribution to international trade and commerce, scientific advancement, and especially our everyday lives.</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Mon, 20 May 2013 02:09:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1823</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1821/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1821</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1821&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR and Cytos bring Singapore's first influenza vaccine to clinical testing</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1821/Default.aspx</link><description>
Singapore’s Agency for Science, Technology and Research (A*STAR) and Switzerland’s Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos’ proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase 1 clinical trial, the safety and immunogenicity of this novel vaccine candidate and its potential to protect against H1N1 influenza infection will be evaluated.

 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
  
  
   
   
   
   
   
   
   
   
   
   
   
  


 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-style-parent:"";
	line-height:115%;
	font-size:11.0pt;"Calibri","sans-serif";}

</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Fri, 17 May 2013 02:07:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1821</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1815/Singapore-as-Asias-Innovation-Capital.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1815</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1815&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Singapore as Asia’s Innovation Capital</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1815/Singapore-as-Asias-Innovation-Capital.aspx</link><description>
 
  leea77
  12.00
 

Singapore has received recognition in five global tracking studies in the area of Innovation and Research and Development (R&amp;amp;D). After 20 years of long term commitment to Science and Technology planning and investments, these indicators provide validation that Singapore is forging ahead towards becoming Asia’s Innovation Capital.

 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
  
  MicrosoftInternetExplorer4
  
   
   
   
   
   
   
   
   
   
   
   
  


 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-style-parent:"";
	line-height:115%;
	font-size:11.0pt;"Calibri","sans-serif";}

</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Wed, 15 May 2013 01:37:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1815</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1813/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1813</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1813&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR’S GET-UP Programme Marks 10 Years of Successful Partnership With SMES </title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1813/Default.aspx</link><description>Singapore, 14 May 2013—A*STAR’s Growing Enterprises through Technology Upgrade (GET-Up) programme today marked its 10-year milestone of strategic partnership with local Small and Medium Enterprises (SMEs) to upgrade their technological capabilities. Since its launch in 2003, the initiative has benefited over 400 companies across the electronic, infocomm, chemical, and biomedical science clusters.</description><dc:creator>Alfi</dc:creator><pubDate>Tue, 14 May 2013 04:48:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1813</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1812/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1812</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1812&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Lloyd’s Register and A*STAR IHPC Open Joint Laboratory to Pursue R&amp;D on Technical Innovations in the Energy and Marine Industries</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1812/Default.aspx</link><description>Lloyd’s Register (LR) and A*STAR’s Institute of High Performance Computing (IHPC) have officially opened a joint laboratory, which will deliver innovative technological solutions to address the challenges faced by the marine, energy and offshore sectors</description><dc:creator>Alfi</dc:creator><pubDate>Fri, 10 May 2013 07:05:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1812</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1811/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1811</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1811&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR’s Genome Institute of Singapore partners Oxford Biodynamics to discover and monitor cells for pathologies or abnormalities</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1811/Default.aspx</link><description>

&amp;#160;The Genome Institute of Singapore (GIS) from the Agency for Science, Technology and Research (A*STAR) and Oxford Biodynamics (OBD) will collaborate to identify epigenetic signatures utilising OBD’s proprietary EpiSwitchTM biomarker discovery platform that can robustly differentiate or confirm the epigenetic footprint of Induced Pluripotent Stem Cells (IPSCs), Embryonic Stem Cells (EC-ESCs) or Progenitor Cells from representative cell lines.
 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
   
  
  
   
   
   
   
   
   
   
   
   
   
   
  


 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-style-parent:"";
	font-size:11.0pt;"Calibri","sans-serif";
	mso-fareast-"Times New Roman";
	mso-bidi-"Times New Roman";}


</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Fri, 10 May 2013 06:42:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1811</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1809/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1809</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1809&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Institute for Infocomm Research (I2R), Singapore’s largest ICT research institute, collaborates with globally competitive companies and invents impactful technologies anchored by scientific research</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1809/Default.aspx</link><description>
 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
  
  MicrosoftInternetExplorer4
  
   
   
   
   
   
   
   
   
   
   
   
  

The Institute for Infocomm Research (I2R), a research institute of the Agency for Science, Technology and Research (A*STAR) announced two collaborations with ST Electronics (Info-Comm Systems) and Singapore Power in the areas of Software Defined Communications systems and Grid Networks respectively. The collaborations are in line with I2R’s directions to develop a wide spectrum of capabilities in the Intelligence, Communications and Multi-media (ICM) sectors of the industry. 


 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-style-parent:"";
	line-height:115%;
	font-size:11.0pt;"Calibri","sans-serif";}

</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Wed, 08 May 2013 11:00:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1809</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1808/Default.aspx#Comments</comments><slash:comments>2</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1808</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1808&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Shikino High-Tech kicks off R&amp;D in Singapore with A*STAR Institute of Microelectronics</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1808/Default.aspx</link><description>Singapore, 6 May 2013 – Shikino High-Tech Co., Ltd., a market leader in camera systems and image processing modules, with extensive experience in IP core licensing, has signed a research agreement with A*STAR Institute of Microelectronics (IME) to develop a low power and high performance Gyro-sensor ASIC IP block for commercial hand held applications.</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Mon, 06 May 2013 07:31:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1808</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1807/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1807</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1807&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Young scientific talents present novel solutions to health, environment and engineering issues</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1807/Default.aspx</link><description>
Student research projects at two major science competitions for youths turned the spotlight on young minds and showcased the innovative solutions they believe could combat the health, environment and engineering problems of city living.

 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
  
  
   
   
   
   
   
   
   
   
   
   
   
  


 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-style-parent:"";
	font-size:10.0pt;"Calibri","sans-serif";}

</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Fri, 26 Apr 2013 08:23:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1807</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1806/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1806</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1806&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR and Veredus Laboratories Create Market’s First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases </title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1806/Default.aspx</link><description>The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample.</description><dc:creator>Alfi</dc:creator><pubDate>Thu, 25 Apr 2013 02:52:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1806</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1805/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1805</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1805&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Understanding Abnormal Proteins in Degenerative Diseases</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1805/Default.aspx</link><description>Amyloids, or fibrous aggregates of abnormally folded proteins, are a common feature in degenerative diseases such as Alzheimer’s, diabetes and cancer. Amyloids occur naturally in the body, but despite decades of research, their mechanism of formation remains unknown, hampering drug development efforts. Now, a new class of ultrasmall peptides developed by the Institute of Bioengineering and Nanotechnology (IBN) offers scientists a platform for understanding this phenomenon, providing them with the insights required to design more effective treatments for these diseases.</description><dc:creator>Alfi</dc:creator><pubDate>Mon, 22 Apr 2013 08:30:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1805</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1804/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1804</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1804&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Singapore scientist wins coveted Chen New Investigator Award 2013</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1804/Default.aspx</link><description>Dr Patrick Tan from A*STAR’s Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO). This award is given to scientists who have made significant contributions to their respective fields of human genetic and genomic research during their early career years, normally within 15 years from receiving their highest earned degree.</description><dc:creator>Alfi</dc:creator><pubDate>Thu, 18 Apr 2013 02:26:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1804</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1803/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1803</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1803&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR scientists decipher genome code of a living fossil</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1803/Default.aspx</link><description>
 
  Normal
  0
  
  
  
  
  false
  false
  false
  
  EN-GB
  X-NONE
  X-NONE
  
   
   
   
   
   
   
   
   
   
   
   
  
  
   
   
   
   
   
   
   
   
   
   
   
  

An enigmatic prehistoric fish has brought scientists at A*STAR’s Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code. Findings from the study are providing new insights into the evolutionary history of the African coelacanth and possible clues as to how aquatic creatures transitioned to life on land.</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Thu, 18 Apr 2013 01:00:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1803</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1802/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1802</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1802&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Singapore Single-Cell Research Centre Opens Door for Asian Biological Discoveries</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1802/Default.aspx</link><description>Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.</description><dc:creator>Alfi</dc:creator><pubDate>Fri, 12 Apr 2013 01:24:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1802</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1801/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1801</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1801&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR, NUS unite ASEAN Health Experts in Fight Against Hand, Foot and Mouth Disease in the region</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1801/Default.aspx</link><description>The Agency for Science, Technology and Research (A*STAR) and the Yong Loo Lin School of Medicine, NUS, are jointly organising the first ASEAN Hand, Foot and Mouth (HFMD) scientific workshop from 11th to 12th April. This inaugural workshop, conducted under the auspices of the ASEAN Committee on Science and Technology (COST) Health Flagship, is part of a greater vision to strengthen the ASEAN region’s public health systems and its capacity to prevent, treat and control emerging infectious diseases.</description><dc:creator>Alfi</dc:creator><pubDate>Thu, 11 Apr 2013 07:42:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1801</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1800/Default.aspx#Comments</comments><slash:comments>2</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1800</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1800&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Australia and Singapore Join Forces to Tackle Emerging Infectious Diseases</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1800/Default.aspx</link><description>Five research teams in Australia and Singapore awarded A*STAR-NHMRC joint grant to design ways to combat disease-causing bugs</description><dc:creator>Alfi</dc:creator><pubDate>Wed, 10 Apr 2013 06:36:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1800</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1798/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1798</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1798&amp;PortalID=0&amp;TabID=828</trackback:ping><title>GlaxoSmithKline and A*STAR’s Institute of Chemical Engineering and Sciences To Develop New Medicines For Emerging Markets</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1798/Default.aspx</link><description>GlaxoSmithKline (GSK) and A*STAR’s Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (EBFs) specifically for emerging markets. EBFs are medicines which are reformulated to provide additional patient benefit.</description><dc:creator>Alfi</dc:creator><pubDate>Tue, 09 Apr 2013 02:45:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1798</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1797/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1797</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1797&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR Scientist Alex Matter Awarded Prestigious Szent-Györgyi Prize For Progress In Cancer Research</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1797/Default.aspx</link><description>Professor Alex Matter, Chief Executive Officer of A*STAR’s Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Györgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.</description><dc:creator>Alfi</dc:creator><pubDate>Fri, 05 Apr 2013 01:43:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1797</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1796/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1796</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1796&amp;PortalID=0&amp;TabID=828</trackback:ping><title>IBN Executive Director Professor Jackie Y. Ying Elected as 2013 Materials Research Society Fellow</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1796/Default.aspx</link><description>IBN Executive Director Professor Jackie Y. Ying was recently selected as a 2013 Materials Research Society (MRS) Fellow for her distinguished contributions to the synthesis of advanced nanostructured materials with unique functionalities for catalytic and biomaterial applications and for her distinguished service to the materials community. MRS is the world’s largest organization of materials researchers from academia, industry, and government that promotes communication for the advancement of interdisciplinary materials research to improve the quality of life.</description><dc:creator>Nur Fahiza</dc:creator><pubDate>Thu, 04 Apr 2013 02:33:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1796</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1795/Default.aspx#Comments</comments><slash:comments>1</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1795</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1795&amp;PortalID=0&amp;TabID=828</trackback:ping><title>New Singapore plastic film is the future of 3D on-the-go</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1795/Default.aspx</link><description>Temasek Polytechnic (TP) and A*STAR’s Institute of Materials Research and Engineering’s (IMRE) new nano-engineered screen protector that turns the ordinary screens of handheld devices into 3D displays will be marketed by start-up, Nanoveu Pte Ltd. The unique plastic film can also potentially be used as next generation security tokens employed by banks and corporations.</description><dc:creator>Alfi</dc:creator><pubDate>Tue, 02 Apr 2013 06:08:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1795</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1794/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1794</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1794&amp;PortalID=0&amp;TabID=828</trackback:ping><title>A*STAR Hosts Nobel Laureate and Renowned Stem Cell Expert Professor Shinya Yamanaka</title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1794/Default.aspx</link><description>Professor Shinya Yamanaka, Nobel Laureate in Medicine or Physiology 2012, has been invited to speak at Biopolis under the A*STAR Biomedical Research Council Distinguished Visitor Programme (DVP).</description><dc:creator>Alfi</dc:creator><pubDate>Tue, 02 Apr 2013 05:04:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1794</guid></item><item><comments>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1792/Default.aspx#Comments</comments><slash:comments>0</slash:comments><wfw:commentRss>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/RssComments.aspx?TabID=828&amp;ModuleID=1561&amp;ArticleID=1792</wfw:commentRss><trackback:ping>http://www.a-star.edu.sg/DesktopModules/DnnForge%20-%20NewsArticles/Tracking/Trackback.aspx?ArticleID=1792&amp;PortalID=0&amp;TabID=828</trackback:ping><title>Singapore’s UTAC to Co-Develop 2.5D Through-Silicon-Interposer With A*STAR’S Institute of Microelectronics for Volume Manufacturing </title><link>http://www.a-star.edu.sg/Media/News/PressReleases/tabid/828/articleType/ArticleView/articleId/1792/Default.aspx</link><description>A*STAR’s Institute of Microelectronics (IME) and United Test and Assembly Center (UTAC), a leading outsourced assembly and test (OSAT) provider, have announced a collaboration to develop a 2.5D Through-Silicon-Interposer (TSI) platform which will enable UTAC to join the scarce list of suppliers in offering fine-pitch 2.5D TSI packaging solutions.&amp;#160;</description><dc:creator>Alfi</dc:creator><pubDate>Thu, 28 Mar 2013 02:05:00 GMT</pubDate><guid isPermaLink="false">f1397696-738c-4295-afcd-943feb885714:1792</guid></item></channel></rss>